|
1
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hung CM, Chang CC, Lin CW, Chen CC and Hsu
YC: GADD45γ induces g2/M arrest in human pharynx and nasopharyngeal
carcinoma cells by cucurbitacin E. Sci Rep. 4:64542014. View Article : Google Scholar
|
|
3
|
Lee AW, Sze WM, Au JS, Leung SF, Leung TW,
Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al: Treatment results
for nasopharyngeal carcinoma in the modern era: the Hong Kong
experience. Int J Radiat Oncol Biol Phys. 61:1107–1116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang
PF, Li C, Peng F, Tang CE, Li JL, et al: Identification of
biomarkers for predicting nasopharyngeal carcinoma response to
radiotherapy by proteomics. Cancer Res. 70:3450–3462. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lorenz U: SHP-1 and SHP-2 in T cells: two
phosphatases functioning at many levels. Immunol Rev. 228:342–359.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Banville D, Stocco R and Shen SH: Human
protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate
promoter usage and exon skipping generate multiple transcripts.
Genomics. 27:165–173. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evren S, Wan S, Ma XZ, Fahim S, Mody N,
Sakac D, Jin T and Branch DR: Characterization of SHP-1 protein
tyrosine phosphatase transcripts, protein isoforms and phosphatase
activity in epithelial cancer cells. Genomics. 102:491–499. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakase K, Cheng J, Zhu Q and Marasco WA:
Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells
and its silencing in HTLv-1-transformed T cells. J Leukoc Biol.
85:165–174. 2009. View Article : Google Scholar :
|
|
9
|
Delibrias CC, Floettmann JE, Rowe M and
Fearon DT: Downregulated expression of SHP-1 in Burkitt lymphomas
and germinal center B lymphocytes. J Exp Med. 186:1575–1583. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oka T, Yoshino T, Hayashi K, Ohara N,
Nakanishi T, Yamaai Y, Hiraki A, Sogawa CA, Kondo E, Teramoto N, et
al: Reduction of hematopoietic cell-specific tyrosine phosphatase
SHP-1 gene expression in natural killer cell lymphoma and various
types of lymphomas/leukemias: combination analysis with cDNA
expression array and tissue microarray. Am J Pathol. 159:1495–1505.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sato K, Horiuchi M, Yo R and Nakarai I: A
long survival case of small cell lung cancer synchronized with
renal cancer. Kyobu Geka. 44:251–253. 1991.In Japanese. PubMed/NCBI
|
|
12
|
Amin HM, Hoshino K, Yang H, Lin Q, Lai R
and Garcia-Manero G: Decreased expression level of SH2
domain-containing protein tyrosine phosphatase-1 (Shp1) is
associated with progression of chronic myeloid leukaemia. J Pathol.
212:402–410. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
López-Ruiz P, Rodriguez-Ubreva J, Cariaga
AE, Cortes MA and Colás B: SHP-1 in cell-cycle regulation.
Anticancer Agents Med Chem. 11:89–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duró JC: Postmenopausal osteoporosis. Med
Clin (Barc). 85:506–509. 1985.In Spanish.
|
|
15
|
Peng G, Cao RB, Li YH, Zou ZW, Huang J and
Ding Q: Alterations of cell cycle control proteins SHP 1/2, p16,
CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma
cells. Mol Med Rep. 10:1709–1716. 2014.PubMed/NCBI
|
|
16
|
Cao R, Ding Q, Li P, Xue J, Zou Z, Huang J
and Peng G: SHP1-mediated cell cycle redistribution inhibits
radiosensitivity of non-small cell lung cancer. Radiat Oncol.
8:1782013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schibli RA: Lung biopsy in interstitial
pulmonary processes. Schweiz Med Wochenschr. 106:467–468. 1976.In
German. PubMed/NCBI
|
|
18
|
Tassidis H, Culig Z, Wingren AG and
Härkönen P: Role of the protein tyrosine phosphatase SHP-1 in
interleukin-6 regulation of prostate cancer cells. Prostate.
70:1491–1500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jackson SP and Bartek J: The DNA-damage
response in human biology and disease. Nature. 461:1071–1078. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reynolds P, Anderson JA, Harper JV, Hill
MA, Botchway SW, Parker AW and O’Neill P: The dynamics of Ku70/80
and DNA-PKcs at DSBs induced by ionizing radiation is dependent on
the complexity of damage. Nucleic Acids Res. 40:10821–10831. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jakob B, Splinter J, Conrad S, Voss KO,
Zink D, Durante M, Löbrich M and Taucher-Scholz G: DNA
double-strand breaks in heterochromatin elicit fast repair protein
recruitment, histone H2AX phosphorylation and relocation to
euchromatin. Nucleic Acids Res. 39:6489–6499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lieber MR: The mechanism of double-strand
DNA break repair by the nonhomologous DNA end-joining pathway. Annu
Rev Biochem. 79:181–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmid TE, Dollinger G, Beisker W, Hable
V, Greubel C, Auer S, Mittag A, Tarnok A, Friedl AA, Molls M, et
al: Differences in the kinetics of gamma-H2AX fluorescence decay
after exposure to low and high LET radiation. Int J Radiat Biol.
86:682–691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rao VA, Agama K, Holbeck S and Pommier Y:
Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I
and II induces histone gamma-H2AX as a biomarker of DNA damage.
Cancer Res. 67:9971–9979. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maacke H, Jost K, Opitz S, Miska S, Yuan
Y, Hasselbach L, Lüttges J, Kalthoff H and Stürzbecher HW: DNA
repair and recombination factor Rad51 is over-expressed in human
pancreatic adenocarcinoma. Oncogene. 19:2791–2795. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hall EJ and Giaccia A: Cell survival
curves. Radiobiology for the Radiologist. 7th edition. Lippincott
Williams and Wilkins; New York, NY: 2011
|
|
27
|
Feng Z, Xu S, Liu M, Zeng YX and Kang T:
Chk1 inhibitor Gö6976 enhances the sensitivity of nasopharyngeal
carcinoma cells to radiotherapy and chemotherapy in vitro and in
vivo. Cancer Lett. 297:190–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou W, Sun M, Li GH, Wu YZ, Wang Y, Jin
F, Zhang YY, Yang L and Wang DL: Activation of the phosphorylation
of ATM contributes to radioresistance of glioma stem cells. Oncol
Rep. 30:1793–1801. 2013.PubMed/NCBI
|
|
29
|
Biddlestone-Thorpe L, Sajjad M, Rosenberg
E, Beckta JM, Valerie NC, Tokarz M, Adams BR, Wagner AF, Khalil A,
Gilfor D, et al: ATM kinase inhibition preferentially sensitizes
p53-mutant glioma to ionizing radiation. Clin Cancer Res.
19:3189–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu B, Wang H, Wang X, Lu HR, Huang C,
Powell SN, Huebner K and Wang Y: Fhit and CHK1 have opposing
effects on homologous recombination repair. Cancer Res.
65:8613–8616. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Wang H, Powell SN, Iliakis G and
Wang Y: ATR affecting cell radiosensitivity is dependent on
homologous recombination repair but independent of nonhomologous
end joining. Cancer Res. 64:7139–7143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Hu B, Liu R and Wang Y: CHK1
affecting cell radio-sensitivity is independent of non-homologous
end joining. Cell Cycle. 4:300–303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY
and Qin J: SMC1 is a downstream effector in the ATM/NBS1 branch of
the human S-phase checkpoint. Genes Dev. 16:571–582. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Falck J, Petrini JH, Williams BR, Lukas J
and Bartek J: The DNA damage-dependent intra-S phase checkpoint is
regulated by parallel pathways. Nat Genet. 30:290–294. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kaufmann WK: The human intra-S checkpoint
response to UVC-induced DNA damage. Carcinogenesis. 31:751–765.
2010. View Article : Google Scholar :
|
|
36
|
Kim ST, Xu B and Kastan MB: Involvement of
the cohesin protein, Smc1, in Atm-dependent and independent
responses to DNA damage. Genes Dev. 16:560–570. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luo H, Li Y, Mu JJ, Zhang J, Tonaka T,
Hamamori Y, Jung SY, Wang Y and Qin J: Regulation of intra-S phase
checkpoint by ionizing radiation (IR)-dependent and IR-independent
phosphorylation of SMC3. J Biol Chem. 283:19176–19183. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sørensen CS, Syljuåsen RG, Falck J,
Schroeder T, Rönnstrand L, Khanna KK, Zhou BB, Bartek J and Lukas
J: Chk1 regulates the S phase checkpoint by coupling the
physiological turnover and ionizing radiation-induced accelerated
proteolysis of Cdc25A. Cancer Cell. 3:247–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
